To respond to concerns that there is a need for a FASTER APPROVAL PROCESS for drugs to treat desperately ill patients > > the FDA issued SPECIAL REGULATIONS describing procedures for EXPEDITING the approval of these types of products. PROVIDE FOR THE REVIEW AND APPROVAL of a new drug AT AN EARLIER STAGE in the clinical testing program